Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
- 1 June 2003
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 168 (2), 213-220
- https://doi.org/10.1016/s0021-9150(03)00050-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prevention of diabetic nephropathy in mice by a diet low in glycoxidation productsDiabetes/Metabolism Research and Reviews, 2002
- von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Cardiovascular risk factors in Type 2 diabetes: the role of hyperglycaemiaExperimental and Clinical Endocrinology & Diabetes, 1999
- Synthesis and secretion of tumour necrosis factor-α by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproductsImmunology Letters, 1997
- Mouse Models of AtherosclerosisScience, 1996
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- Identification of Glyoxal and Arabinose as Intermediates in the Autoxidative Modification of Proteins by GlucoseBiochemistry, 1995
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsCell, 1992
- New Aspects of the Maillard Reaction in Foods and in the Human BodyAngewandte Chemie-International Edition, 1990
- Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue RemodelingScience, 1988